Viewing Study NCT00402467


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-03-26 @ 3:52 PM
Study NCT ID: NCT00402467
Status: COMPLETED
Last Update Posted: 2014-12-23
First Post: 2006-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module